Punters position for potential lithium find
It’s in a trading halt but a potential lithium find at Raiden Resources seems to have investors piling into neighbour Errawarra.
It’s in a trading halt but a potential lithium find at Raiden Resources seems to have investors piling into neighbour Errawarra.
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the Lucapa Diamond Company’s Merlin restart in the Northern Territory.
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new human pharmacokinetic study from Neurotech.
This week on Tony’s Takeaway, Locantro wants to share his sides with you – his six ‘McMining Nuggets’, starting with Far East Gold.
Drumroll… it’s Pilbara Minerals. And that’s despite the lithium prices tracking upwards just lately.
While three of the biggest building material companies have been taken over, there are still opportunities to tap an expected recovery in housing activity.
Following key online promotional events, EZZ Life Sciences reports surging Chinese sales of its health and beauty products.
Australia’s love of betting is as strong as ever, although the wagering market is consolidating. One asset manager is tipping BlueBet and PointsBet to succeed.
Supermajor Shell’s reportedly successful appraisal program at the Taroom Trough could pry the play open to ease east coast gas woes.
Western Australia’s remote Paterson Province is looking interesting once again, particularly for junior explorer Antipa Minerals. Kristie Batten reports.
AusQuest has been riding with South32 for eight years. Is it on the cusp of a major discovery?
RFC Ambrian says gold forecasters tend to underpredict future prices 80% of the time, with bullion regularly making analysts look silly.
One of the world’s top lithium companies has taken a shine to ASX junior iTech Minerals in a frontier exploration JV.
The ASX rose on Friday on energy gains and A2 Milk’s spurt, while WiseTech and Megaport dragged tech down and Bitcoin soared (again).
As Donald Trump’s second term in the Oval Office looms, global markets face a seismic shift with opportunities and risks both firmly in play, writes Nigel Green.
Three companies, including Orica, Sims, and Australian Vintage, were recognised for their strong ESG efforts in 2024.
Morgans analyst Scott Power notes global healthcare markets have fallen after Trump’s appointment of RFK Jr as Secretary of US Department of Health and Human Services.
The ASX has risen on Friday on energy gains, while tech stocks have dropped on the back of WiseTech, Megaport sell-offs.
In this episode, host Fraser Palamara delves into 5E Advanced Materials’ (ASX:5EA) achieving its first full truckload shipment of boric acid super sacks to a US customer.
In this episode, host Fraser Palamara tells all on AML3D (ASX:AL3) more than doubling its US manufacturing capacity on the back of a successful $30 million capital raise.
In this week’s big cap miner news, MinRes holds a frosty AGM and BHP pulls back the curtain on copper spend.
Hillgrove Resources is aiming to become the next ASX copper success story, as it explores and grows its reborn Kanmantoo mine.
Rhythm Biosciences has raised $3.5m and plans to commercialise the second generation of its bowel cancer blood test Colostat in 2025.
Green Technology Metals managing director Cameron Henry joins Host, Barry FitzGerald, on the Explorers Podcast, to discuss ongoing drilling at its 14.6Mt Root lithium project in Ontario, Canada.
With M&A and IPOs, corporate activity in ASX lithium companies is making a return of sorts.
The ASX 200 fell on Thursday after a dip in the Discretionary sector, while gold stocks and Bitcoin (in particular) surged.
Encounter Resources has caught the eye of investors after hitting high grade niobium over the fence from WA1’s Luni discovery.
ASX tech stocks offer hidden growth potential for investors looking beyond US tech giants, with a few under-the-radar stocks to consider.
The ASX began Thursday strongly following a US market bounce, but has since flattened out. Meanwhile Nvidia’s latest earnings were deemed a bit ‘meh’ but Bitcoin is still surging.
In this episode, host Fraser Palamara unpacks the niobium drilling success from West Arunta explorer Encounter Resources.
Mayne Pharma and Acrux are capitalising on the ongoing push for lower drug prices, especially in the US.
Something you might not know: we’re in the middle of World Antimicrobial Resistance Awareness Week. These three superbug-tackling ASX health firms are certainly aware.
Expert market analyst Steve Collette believes ASX stock Spartan Resources could have a golden near future.
The ASX dipped on Wednesday as energy stocks led losses. Global tensions weighed on markets but gold stocks rose… all ahead of Nvidia’s incoming earnings report.
Narryer Metals lifted on rare earth hits in WA’s Great Southern, where former Cassini Resources boss Richard Bevan is chasing his next win.
The ASX dips amid geopolitical tensions, Amcor falls on $13 billion acquisition, while Narryer Metals strikes high-grade scandium and rare earths.
Donald Trump’s appointment of Robert F Kennedy Junior as health czar means interesting times for US-focused ASX life sciences plays
Painchek is eyeing a US market of 1.7 million aged-care beds for its mobile-based pain detection tool.
The ASX kissed a record high on Tuesday, led by tech, energy and gold stocks, with gold rising above US$2600.
The ASX IPO market is picking up after a quiet 2024 with major listings ahead, including Symal, Fulcrum and Cuscal.
Metallurgical testing has proved that titanium minerals are present at the Rosewood prospect – a huge boost for Petratherm.
The ASX has risen on Tuesday, with energy stocks up and Petratherm hitting high-grade titanium in South Australia.
Pathology and radiology giant Sonic Healthcare is recovering from its post-pandemic malaise and says earnings should improve this year.
Record gold prices and corporate activity have shined a light on WA’s Laverton gold field, where these explorers are chasing new discoveries.
With FDA approval in the bag for its AI-based aortic stenosis diagnostic tool, Echo IQ is focused on commercialisation over the next few years.
The ASX is trading flat as US rate fears weigh. Meanwhile NAB has been hit by a lawsuit and new bank levy, and Alderan jumps on copper-drilling hit in the US.
With a market cap of just $6m, Silver hunter Sierra Nevada Gold may be the next cab off the rank in the ASX silver revival.
The ASX closing bell has rung, with the local bourse ending Monday on a positive note. Mining gains offset tech and bank losses, while uranium stocks soared.
A $13.5m tungsten deal, a cheap silver explorer and a uranium enrichment play are among the Aussie resources stocks posting gains on Monday.
Harvard University’s main teaching hospital will use Echo IQ’s AI-based Echosolv tool to detect aortic stenosis (heart valve disease). Tim Boreham reports.
Geothermal and nuclear energy have emerged as the top choice to power Big Tech’s data centres. These ASX companies are on the case.
Pilbara Minerals tops the ASX short-selling list again, but buying heavily shorted stocks could trigger a short squeeze.
Australia is poised to become a health and medical products manufacturing powerhouse, according to government and industry leaders.
In this week’s Ethical Investor Eddy Sunarto looks at the COP29 conference, where leaders are discussing carbon-credit trading rules, a crypto levy, and a 10x in climate finance.
Emerging competing takeover offers for SelfWealth and E&P Financial’s pending privatisation reflect the poor track record of the listed brokers.
Mining doyen Barry FitzGerald looks at the potential for a turnaround at Aeris Resources with the copper market preparing for liftoff.
Vale has taken a keen interest in unheralded junior Cyclone Metals, entering a non-binding MoU over its Iron Bear iron ore project in Canada.
The ASX rose on Friday, with NoviqTech almost tripling on blockchain funding. MinRes, however, dipped again and US Fed boss Jerome Powell cooled rate-cut hopes.
Morgans healthcare analyst Scott Power notes that while the S&P/ASX 200 Health Care index is down 1.4% over the past five days, some firms have soared on positive news.
Typically a safe haven asset, gold could recover its trajectory in a Trump 2.0 presidency according to the World Gold Council.
The ASX is on the rise on Friday, despite the Fed boss’s hawkish stance. Also, MinRes has admitted a slip-up and Cyclone Metals has surged after a deal with Vale.
Good morning! Here’s everything you need to know before the ASX opens today.
Falling critical minerals prices have hit 50 of Australia’s largest miners, delivering a 37 per cent collective hit to their earnings in 2024.
The Aussie ETF industry has reached $233 billion with international stocks leading inflows, while Betashares launched an ethical Aussie bond ETF.
Chinese car maker BYD appears set to overtake US giant Ford in annual EV shipments. That’s largely because of demand for hybrids – which are also booming in Australia.
WA-based gas stocks have every reason to cheer Asian demand growth – and a recent state government decision. Meanwhile, others are getting busy in SA and Queensland.
Variscan Mines has reawakened after returning with underground drilling at a zinc mine in Spain ignored for almost 100 years.
Collette Capital’s Steve Collette says interest is returning in semiconductor stock Archer Materials, which is eyeing new resistance levels after a mid-year slump.
ASX stock Actinogen reports its advanced – and novel – Alzheimer’s disease trial is recruiting strongly, with first results expected by mid next year.
Stockhead TV brings you today’s Break it Down, detailing the initial inferred resource estimate from Far East Gold’s Indonesian Idenburg project.
Mt Isa’s underground copper mines are set to close in 2025, but Queensland explorers are looking to step into the breach.
These ASX health stocks, which are cashing in on Chinese enthusiasm for Australian products, found a massive audience at the world’s largest trade show.
Guy Le Page goes into post-Trump metals markets before looking at Capricorn-adjacent Peregrine Gold as his stock of the week.
Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes Tim Boreham.
The Trump administration is expected to liberalise research into psychedelic-assisted therapies – and Emyria investors have taken note. Read more in our health wrap.
BMG Resources and Metal Hawk are preparing to drill down on gold projects in WA’s northern Goldfields.
Western Gold Resources’ CEO Cullum Winn joins Barry FitzGerald on the Explorers Podcast to talk about the company’s Gold Duke project in the Goldfields region of Western Australia.
The ASX dropped on Wednesday as banks and miners slid, with MinRes falling hard. And Trump has tapped Musk to lead a new DOGE department. Yep, you read that right.
Bank stocks have fallen on the ASX on Wednesday, with gold dipping below $US2600. The news has been better for Nvidia, as it hit record highs.
Host Fraser Palamara explains the major autism and ADHD study BlinkLab is getting involved in with Melbourne’s Monash University.
Original URL: https://www.news.com.au/finance/business/stockhead/news/page/22